PROPANC BIOPHARMA INC (PPCB) Stock Price, Quote, News and Overview
NASDAQ:PPCB - Nasdaq - US74346N7012 - Common Stock - Currency: USD
PPCB Quote, Performance and Key Statistics
2.87
+2.87 (+Infinity%)
The current stock price of PPCB is 2.87 USD.
PPCB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.52 | 365.10B | ||
| AMGN | AMGEN INC | 13.59 | 159.41B | ||
| GILD | GILEAD SCIENCES INC | 15.29 | 147.24B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.19 | 100.87B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 62.67B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.53B | ||
| ARGX | ARGENX SE - ADR | 70.53 | 40.01B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.92 | 34.78B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.29B | ||
| INSM | INSMED INC | N/A | 24.24B | ||
| NTRA | NATERA INC | N/A | 22.26B | ||
| BIIB | BIOGEN INC | 8.66 | 20.31B |
Related stock screener links
About PPCB
Company Profile
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on a pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.
Company Info
PROPANC BIOPHARMA INC
302/6 Butler Street, Camberwell
Melbourne VICTORIA AU
Employees: 0
Phone: 61398820780
PROPANC BIOPHARMA INC / PPCB FAQ
What is the stock price of PROPANC BIOPHARMA INC today?
The current stock price of PPCB is 2.87 USD.
What is the ticker symbol for PROPANC BIOPHARMA INC stock?
The exchange symbol of PROPANC BIOPHARMA INC is PPCB and it is listed on the Nasdaq exchange.
On which exchange is PPCB stock listed?
PPCB stock is listed on the Nasdaq exchange.
What is PROPANC BIOPHARMA INC worth?
PROPANC BIOPHARMA INC (PPCB) has a market capitalization of 33.32M USD. This makes PPCB a Nano Cap stock.
How many employees does PROPANC BIOPHARMA INC have?
PROPANC BIOPHARMA INC (PPCB) currently has 0 employees.
Should I buy PROPANC BIOPHARMA INC (PPCB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PPCB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PPCB, evaluating the profitability, health, valuation and growth aspects
- PROPANC BIOPHARMA INC (PPCB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PROPANC BIOPHARMA INC (PPCB) Sales and EPS estimates to see what analysts future expectations are.
- PROPANC BIOPHARMA INC (PPCB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PROPANC BIOPHARMA INC (PPCB) Insider and Institutional Ownership to learn about the owners and their transactions.
- PROPANC BIOPHARMA INC (PPCB) Stock Chart to make your own analysis
- PROPANC BIOPHARMA INC (PPCB) Latest news and press-releases to stay up to date.
Does PROPANC BIOPHARMA INC (PPCB) stock pay dividends?
PPCB does not pay a dividend.
What is the Price/Earnings (PE) ratio of PROPANC BIOPHARMA INC (PPCB)?
PROPANC BIOPHARMA INC (PPCB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-703.62).
PPCB Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PPCB.
PPCB Financial Highlights
Over the last trailing twelve months PPCB reported a non-GAAP Earnings per Share(EPS) of -703.62. The EPS increased by 98.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2147.26% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |